Autoimmunity in 2017
C Selmi - Clinical Reviews in Allergy & Immunology, 2018 - Springer
… study on the risk of developing autoimmune diseases after human papilloma virus (HPV) …
the present study show that there is no increased risk of developing any autoimmune condition …
the present study show that there is no increased risk of developing any autoimmune condition …
Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases
N Zhang, KS Nandakumar - Vaccine, 2018 - Elsevier
… risk factors associated with chronic inflammatory autoimmune diseases, such as rheumatoid
arthritis (… Current advances in the development of vaccines for such autoimmune diseases, …
arthritis (… Current advances in the development of vaccines for such autoimmune diseases, …
Evolution of biomarker research in autoimmunity conditions for health professionals and clinical practice
A Dudaev, M Studneva, J Aitken, S Blokh… - Progress in Molecular …, 2022 - Elsevier
… to the development of general autoimmunity theory: it has put the … of current knowledge
and prognostic perspectives toward catalytic Abs in autoimmunity and thus some autoimmune …
and prognostic perspectives toward catalytic Abs in autoimmunity and thus some autoimmune …
The challenge of modulating β-cell autoimmunity in type 1 diabetes
MA Atkinson, BO Roep, A Posgai… - The Lancet Diabetes & …, 2019 - thelancet.com
With the conceptual advance about four decades ago that type 1 diabetes represents an
autoimmune disease, hope arose that immune-based therapies would soon emerge to prevent …
autoimmune disease, hope arose that immune-based therapies would soon emerge to prevent …
Challenges to vaccination against SARS-CoV-2 in patients with immune-mediated diseases
… Taken together, patients with autoimmune/rheumatic disorders showed a good humoral
and cellular response to the vaccination challenge (85% response for both parameters). …
and cellular response to the vaccination challenge (85% response for both parameters). …
Type I interferon detection in autoimmune diseases: challenges and clinical applications
VE Papadopoulos, C Skarlis… - Expert Review of …, 2021 - Taylor & Francis
… in the pathogenesis of several autoimmune diseases. Here, we summarize current knowledge
regarding the role of type I IFNs in the major systemic autoimmune diseases, including …
regarding the role of type I IFNs in the major systemic autoimmune diseases, including …
Autoimmune pemphigus: latest advances and emerging therapies
… In this case, acantholysis is caused by autoimmune disruption … While the main antigenic
targets of these autoimmune skin … offer better treatment of this challenging set of diseases and …
targets of these autoimmune skin … offer better treatment of this challenging set of diseases and …
Autoimmunity as a sequela to obesity and systemic inflammation
VR Kwiat, G Reis, IC Valera, K Parvatiyar… - Frontiers in …, 2022 - frontiersin.org
… importance that we understand how obesity increases susceptibility for several autoimmune
diseases. At present, our understanding of the complex interplay between metabolism and …
diseases. At present, our understanding of the complex interplay between metabolism and …
Diagnosis and management of autoimmune diseases in the ICU
… by nephrotoxic drugs or volume depletion [9, 10]. Microangiopathic hemolytic anemia is
detected in 43% of cases, and anti-RNA-polymerase III antibodies are present in one-third of …
detected in 43% of cases, and anti-RNA-polymerase III antibodies are present in one-third of …
Immunoglobulin G N-glycan biomarkers for autoimmune diseases: current state and a glycoinformatics perspective
K Flevaris, C Kontoravdi - International Journal of Molecular Sciences, 2022 - mdpi.com
… diseases are grouped into two categories: rheumatic autoimmune diseases and autoimmune
diseases with other pathophysiological features. Rheumatic autoimmune diseases are …
diseases with other pathophysiological features. Rheumatic autoimmune diseases are …